Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

PharmaResearch Co., Ltd. (CEO: Jihoon Sohn) today announced that the U.S. Food and Drug Administration (FDA) has cleared its ...

By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Fully Focused on Rapid Advancement of ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2026 Earnings Call Transcript February 5, 2026 Arrowhead Pharmaceuticals, ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority ...

AMT-191 has been granted both Orphan Drug and Fast Track designation by the U.S. Food and Drug Administration.

VANCOUVER, BC / ACCESS Newswire / February 5, 2026 / LIR Life Sciences Corp. ("LIR" or the "Company) is pleased to announce that it has commenced Project Phase 2 peptide design activities with Neuland ...

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for ...

As a next-generation selective S1P receptor modulator, VELSIPITY® offers the potential for rapid onset of action, and long-lasting clinical remission and mucosal healing through an oral, once-daily ...

This piece has been updated to clarify that, if the deal is signed, the Elara Caring/DaVita care model would not include ...

Biopharmaceutical firm Ocugen has bolstered its financial runway, yet its share price has recently displayed notable softness. The investment community is now l ...